Galmed Pharmaceuticals Other Current Liabilities

Galmed Pharmaceuticals (GLMD) currently reports a other current liabilities of $360K as of March 2026. That compares with $500K in the prior-year period — down 28.9% year over year. Use the charts on this page to explore Galmed Pharmaceuticals's other current liabilities history and peer comparisons.

Galmed Pharmaceuticals's other current liabilities decreased from $500K to $360K — a 28.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Galmed Pharmaceuticals reported $360K in other current liabilities as of March 2026. That compares with $500K in the prior-year period — down 28.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $360K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Galmed Pharmaceuticals, and consider following GLMD for alerts when major investors trade the stock.

Galmed Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $360K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLMD with unrelated industries.